{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:21:45Z","timestamp":1783660905687,"version":"3.55.0"},"reference-count":36,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,11,22]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Percutaneous coronary intervention (PCI), the preferred coronary reperfusion strategy, induces endothelial trauma which may mount an inflammatory response. This has been shown to increase the likelihood of further major adverse cardiovascular events (MACE). Colchicine, a cheap and widely used anti-inflammatory has shown promise in improving cardiovascular outcomes. We aimed to perform a systematic review and meta-analysis to study the effects of colchicine in patients with symptomatic coronary artery disease (CAD) who have undergone PCI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>We systematically reviewed and meta-analysed 7 randomised controlled trials including a total of 6660 patients (colchicine group: 3347, control group: 3313; mean age=60.9\u00b110). Six studies included participants who had a \u226413.5-day history of acute coronary syndrome (ACS). One study included patients with both ACS and chronic coronary syndrome. The follow-up of studies ranged from 3\u2009days to 22.6 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The use of colchicine in patients who underwent PCI significantly reduced MACE outcomes (risk ratio 0.73 (95% CI 0.61 to 0.87); p=0.0003) with minimal heterogeneity across the analysis (I<jats:sup>2<\/jats:sup>=6%; P for Cochran Q=0.38). These results were driven mainly by the reduction in repeat vessel revascularisation, stroke and stent thrombosis. The number needed to treat to prevent one occurrence of MACE was 41.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Colchicine significantly reduced the risk of MACE in patients with CAD who underwent PCI, mostly in the reduction of repeat vessel revascularisation, stroke and stent thrombosis. The efficacy of colchicine should be further studied by distinguishing its use alongside different stent types and dosing regimens.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42021245699.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2021-001887","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T11:40:18Z","timestamp":1641469218000},"page":"e001887","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4405-576X","authenticated-orcid":false,"given":"Kah Long","family":"Aw","sequence":"first","affiliation":[{"name":"Oxford University Hospitals NHS Trust, Oxford, UK"},{"name":"Wycombe Hospital Department of Cardiology, Buckinghamshire Healthcare NHS Trust, High Wycombe, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Koh","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Lin","family":"Lee","sequence":"additional","affiliation":[{"name":"Royal Berkshire NHS Foundation Trust, Reading, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurimas","family":"Kudzinskas","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"De Palma","sequence":"additional","affiliation":[{"name":"Wycombe Hospital Department of Cardiology, Buckinghamshire Healthcare NHS Trust, High Wycombe, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"2025081709543200000_9.1.e001887.1","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2025081709543200000_9.1.e001887.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu505"},{"key":"2025081709543200000_9.1.e001887.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207"},{"key":"2025081709543200000_9.1.e001887.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302699"},{"key":"2025081709543200000_9.1.e001887.5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009127","article-title":"Treating inflammation prior to percutaneous coronary intervention: does the heart care?","volume":"13","author":"Cao","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2025081709543200000_9.1.e001887.6","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2988"},{"key":"2025081709543200000_9.1.e001887.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.12.017"},{"key":"2025081709543200000_9.1.e001887.8","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","article-title":"Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions","volume":"39","author":"Kalkman","year":"2018","journal-title":"Eur Heart J"},{"key":"2025081709543200000_9.1.e001887.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.06.011"},{"key":"2025081709543200000_9.1.e001887.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"2025081709543200000_9.1.e001887.11","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90624-V"},{"key":"2025081709543200000_9.1.e001887.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.055"},{"key":"2025081709543200000_9.1.e001887.13","first-page":"001","article-title":"Colchicine treatment for prevention of in stent restenosis (CISR trial)","volume":"2","author":"Habib","year":"2019","journal-title":"American J Emerg Crit Care Med"},{"key":"2025081709543200000_9.1.e001887.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388"},{"key":"2025081709543200000_9.1.e001887.15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The low dose colchicine after myocardial infarction (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am Heart J"},{"key":"2025081709543200000_9.1.e001887.16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","article-title":"Effects of acute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial","volume":"13","author":"Shah","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2025081709543200000_9.1.e001887.17","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian cops randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"2025081709543200000_9.1.e001887.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.10.027"},{"key":"2025081709543200000_9.1.e001887.19","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025081709543200000_9.1.e001887.20","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur Heart J"},{"key":"2025081709543200000_9.1.e001887.21","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"2025081709543200000_9.1.e001887.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-017-0875-8","article-title":"Number needed to treat (NNT) in clinical literature: an appraisal","volume":"15","author":"Mendes","year":"2017","journal-title":"BMC Med"},{"key":"2025081709543200000_9.1.e001887.23","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i11"},{"key":"2025081709543200000_9.1.e001887.24","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/ehjcvp\/pvaa137","article-title":"Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns","volume":"7","author":"Galli","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025081709543200000_9.1.e001887.25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijcard.2017.02.040","article-title":"Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome","volume":"236","author":"Pedicino","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025081709543200000_9.1.e001887.26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002128"},{"key":"2025081709543200000_9.1.e001887.27","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation","volume":"130","author":"Robertson","year":"2016","journal-title":"Clin Sci"},{"key":"2025081709543200000_9.1.e001887.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706123362402"},{"key":"2025081709543200000_9.1.e001887.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.6.1247"},{"key":"2025081709543200000_9.1.e001887.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.974956"},{"key":"2025081709543200000_9.1.e001887.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.049"},{"key":"2025081709543200000_9.1.e001887.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60141-5"},{"key":"2025081709543200000_9.1.e001887.33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002432"},{"key":"2025081709543200000_9.1.e001887.34","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12305","article-title":"Immune cells in repair of the infarcted myocardium","volume":"24","author":"Chen","year":"2017","journal-title":"Microcirculation"},{"key":"2025081709543200000_9.1.e001887.35","doi-asserted-by":"publisher","DOI":"10.1583\/1545-1550(2002)009<0059:BAASII>2.0.CO;2"},{"key":"2025081709543200000_9.1.e001887.36","unstructured":"Clinicaltrials.gov . CLEAR SYNERGY Neutrophil Substudy - Full Text View, 2021. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03874338 [Accessed 6 June 2021]."}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2021-001887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:54:42Z","timestamp":1755449682000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2021-001887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,6]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/openhrt-2021-001887"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2021-001887","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}